Literature DB >> 1351046

Heatstroke and hyperthermias.

M Amore1, M Cerisoli.   

Abstract

We describe the pathogenesis and the typical clinical and laboratory features of the hyperthermia syndromes that may develop during neuroleptic drug treatment, environmental exposure or following the use of inhalational anesthetics. Since the features are similar and confusion is possible we emphasize the need for prompt diagnosis so that appropriate treatment, can be started without delay. Hyperthermic reactions have common pathophysiological mechanisms and they may be seen as an abnormal individual response to organic and functional stressors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351046     DOI: 10.1007/bf02223099

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  16 in total

1.  Fatal hyperpyrexia during chlorpromazine therapy.

Authors:  F J AYD
Journal:  J Clin Exp Psychopathol       Date:  1956 Apr-Jun

2.  [Acute lethal catatonia].

Authors:  M Amore; M Montanari; M Vitali
Journal:  Minerva Psichiatr       Date:  1986 Oct-Dec

Review 3.  Drug-related heatstroke.

Authors:  W G Clark; J M Lipton
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

4.  Location of receptors mediating hypothermia after injection of dopamine agonists in rats [proceedings].

Authors:  B Cox; T F Lee
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

5.  Heatstroke.

Authors:  R J Anderson; G Reed; J Knochel
Journal:  Adv Intern Med       Date:  1983

6.  Neuroleptic malignant syndrome and dopaminergic blockade.

Authors:  F Hashimoto; C B Sherman; W H Jeffery
Journal:  Arch Intern Med       Date:  1984-03

7.  Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.

Authors:  T Y Lew; G Tollefson
Journal:  Biol Psychiatry       Date:  1983-12       Impact factor: 13.382

8.  Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.

Authors:  H Hermesh; M Huberman; H Radvan; E Kott
Journal:  J Nerv Ment Dis       Date:  1984-11       Impact factor: 2.254

9.  Neuroleptic malignant syndrome superimposed on tardive dyskinesia.

Authors:  J J Haggerty; B S Bentsen; G M Gillette
Journal:  Br J Psychiatry       Date:  1987-01       Impact factor: 9.319

10.  Neuroleptic malignant-like syndrome induced by metoclopramide.

Authors:  M R Samie
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.